Mitochondria as Cell Targets of AZT (Zidovudine)

This publication has 40 references indexed in Scilit:

• AZT side effect on mitochondria does not depend on either inhibition of electron flow or mitochondrial uncoupling.
  International Journal of Molecular Medicine, 1998
• Genotoxicity and mitochondrial damage in human lymphocytic cells chronically exposed to 3′-azido-2′,3′-dideoxythymidine
  Mutation Research - Genetic Toxicology and Environmental Mutagenesis, 1997
• 3′-Azido-3′-deoxythymidine uptake into isolated rat liver mitochondria and impairment of ADP/ATP translocator
  Biochemical Pharmacology, 1997
• Hepatic Morphological Alterations Induced by Zidovudine (ZDV) in an Experimental Model
  Pathology - Research and Practice, 1996
• The effect of zidovudine on skeletal muscle mtDNA in HIV-1 infected patients with mild or no muscle dysfunction
  Brain, 1996
• Mechanisms of toxicity of 3′-azido-3′- deoxythymidine: Its interaction with adenylate kinase
  Biochemical Pharmacology, 1994
• Concurrent zidovudine-induced myopathy and hepatoxicity in patients treated for human immunodeficiency virus (HIV) infection
  Pathology, 1992
• Partial cytochrome c oxidase deficiency and cytoplasmic bodies in patients with zidovudine myopathy
  Neuromuscular Disorders, 1991
• Depletion of muscle mitochondrial DNA in AIDS patients with zidovudine-induced myopathy
  The Lancet, 1991
• Differential Patterns of Intracellular Metabolism of 2′,3′-Didehydro-2′,3′-dideoxythymidine and 3′-Azido-2′,3′-dideoxythymidine, Two Potent Anti-human Immunodeficiency Virus Compounds
  Journal of Biological Chemistry, 1989